Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
Status:
Withdrawn
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ulipristal acetate is effective in the
treatment of females with anemia associated with uterine leiomyomas. The safety of this
product will also be evaluated.